British Society for Haematology guidelines for the management of adult myelodysplastic syndromes

Br J Haematol. 2021 Jul;194(2):267-281. doi: 10.1111/bjh.17612. Epub 2021 Jun 27.
No abstract available

Keywords: MDS; guideline; management; myelodysplastic syndromes.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Anemia / complications
  • Anemia / therapy
  • Antineoplastic Agents / therapeutic use
  • Azacitidine / therapeutic use
  • Blood Transfusion / methods
  • Decitabine / therapeutic use
  • Disease Management
  • Hematinics / therapeutic use
  • Hematopoietic Stem Cell Transplantation / methods
  • Hemorrhage / complications
  • Hemorrhage / therapy
  • Humans
  • Iron Chelating Agents / therapeutic use
  • Myelodysplastic Syndromes* / complications
  • Myelodysplastic Syndromes* / therapy
  • Neutropenia / complications
  • Neutropenia / therapy
  • Thrombocytopenia / complications
  • Thrombocytopenia / therapy

Substances

  • Antineoplastic Agents
  • Azacitidine
  • Decitabine
  • Hematinics
  • Iron Chelating Agents